Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multi-Center Observational Study to Assess the Reliability and Validity of the Multi-Luminance Y-Mobility Test (MLYMT) and Multi-Luminance Shape Discrimination Test (MLSDT)

NCT05820100 is registered in ClinicalTrials.gov with Nanoscope Therapeutics Inc. as lead sponsor.

NCT NCT05820100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05820100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multi-Center Observational Study to Assess the Reliability and Validity of the Multi-Luminance Y-Mobility Test (MLYMT) and Multi-Luminance Shape Discrimination Test (MLSDT)
Lead sponsor
Nanoscope Therapeutics Inc.
Phase
Observational
Overall status
Completed
Start date
April 25, 2023
Completion date
October 17, 2023
Enrollment
35 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

retinal dystrophy, retinitis pigmentosa